Kiyoko Goto and Paul Bourdarie Scientific Prize
Kenichi YOSHIDA, M.D., Ph.D. Wellcome Sanger Institute / Postdoctoral fellow |
Tobacco smoking and somatic mutations in human bronchial epithelium (Nature. 2020;578;266-272.) |
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award
Kenji CHAMOTO, Ph.D. Department of Immunology and Genomic Medicine Kyoto University Graduate School of Medicine / Associate professor |
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy. (JCI Insight. 2020 Jan 30; 5(2): e133501.Published online 2020 Jan 30.) |
The 10th (2021) laureate
Kiyoko Goto and Paul Bourdarie Scientific Prize
Kazuhito FUNAI, M.D., Ph.D. Associate professor, First Department of Surgery, Hamamatsu University School of Medicine |
Urinary Fluorescent Metabolite O-Aminohippuric Acid is a Useful Biomarker for Lung Cancer Detection (Metabolomics、2020 Sep 17;16(10):101. ) |
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award
Taiki HAKOZAKI, M.D. Staff Physician, Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital |
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (Cancer Immunol Res. 2020;8(10):1243-1250.) |
The 11th (2022) laureate
Kiyoko Goto and Paul Bourdarie Scientific Prize
Hisashi SAJI, M.D., Ph.D. Professor & Chair, Department of Thoracic Surgery, St. Marianna University School of Medicine |
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
(Lancet. 2022 Apr 23;399(10335):1607-1617.) |
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award
Hiroshi ICHISE, Ph.D. Visiting fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health |
Functional visualization of NK cell-mediated killing of metastatic single tumor cells (eLife, 2022; 11, e76269 (1-28)) |
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award
Yoshihisa KOBAYASHI, M.D., Ph.D. Staff Scientist, Division of Molecular Pathology, National Cancer Center Research Institute |
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers. (Nature 2022; 603(7900):335-342.) |
The 12th (2023) laureate
Kiyoko Goto and Paul Bourdarie Scientific Prize
Kentaro TANAKA, M.D., Ph.D. Associate Professor, Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University
(position on April 1st 2024, Associate Professor, Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University) |
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer
(Science Translational Medicine 2022;14 (675):eabq0021) |
Kiyoko Goto and Paul Bourdarie Scientific Prize
Fumihiro SHOJI, M.D., Ph.D. Chief of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center |
Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer (Frontiers in Molecular Bioscience 2022, 9:1040424) |
Fondation contre le cancer Kiyoko Goto et Paul Bourdarie (Reconnue d’utilité publique) Copyright © 2022